Research programme: liver disorders stem cell therapy - Microbot Medical

Drug Profile

Research programme: liver disorders stem cell therapy - Microbot Medical

Alternative Names: hLEC; Human liver engrafting cells - Microbot Medical; Liver Program - Microbot Medical

Latest Information Update: 13 Dec 2016

Price : $50

At a glance

  • Originator StemCells
  • Developer Microbot Medical
  • Class Stem cell therapies
  • Mechanism of Action Tissue replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Liver disorders

Most Recent Events

  • 28 Nov 2016 StemCells has been acquired and merged into Microbot Medical
  • 19 Jul 2012 Preclinical development is ongoing in USA
  • 02 Nov 2010 StemCells receives grant from US Department of Health and Human Services for liver stem cell therapy development in Liver disorders
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top